Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immune Therapeutics names new president, COO

This article was originally published in Scrip

Executive Summary

Immune Therapeutics, a specialty pharmaceutical company developing therapies based on the activation and modulation of the body's immune system, has named Seth Elliott president and chief operating officer. Mr Elliott has spent more than 15 years as a founder or senior executive of emerging growth and middle market enterprises. His previous roles include: chief strategy officer of Engagement Media Technologies; vice-president, business development for FastCall; and founder of Pegasus Advisory group.

Topics

UsernamePublicRestriction

Register

SC027599

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel